To improve the therapeutic potential of peptides that interfere with MDM4 binding to MDM2, we demonstrated the tumor‐suppressive activity of a short peptide (Pep3S), which is composed of the last five amino acids of the MDM4 protein. Here, MDM4 is linked to neoplasm.